McKesson Corporation (MCK): Price and Financial Metrics


McKesson Corporation (MCK): $204.12

1.62 (+0.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MCK POWR Grades


  • Value is the dimension where MCK ranks best; there it ranks ahead of 92.62% of US stocks.
  • MCK's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • MCK's current lowest rank is in the Sentiment metric (where it is better than 46.13% of US stocks).

MCK Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MCK is -11,344.19 -- better than only 0% of US stocks.
  • With a price/sales ratio of 0.13, Mckesson Corp has a higher such ratio than only 1.62% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 22.71 for Mckesson Corp; that's greater than it is for 97.92% of US stocks.
  • Stocks that are quantitatively similar to MCK, based on their financial statements, market capitalization, and price volatility, are ORLY, GSKY, ABC, KXIN, and CSTM.
  • Visit MCK's SEC page to see the company's official filings. To visit the company's web site, go to www.mckesson.com.

MCK Valuation Summary

  • MCK's price/earnings ratio is -7.1; this is 120.88% lower than that of the median Healthcare stock.
  • Over the past 243 months, MCK's price/sales ratio has gone down 0.2.
  • Over the past 243 months, MCK's price/sales ratio has gone down 0.2.

Below are key valuation metrics over time for MCK.

Stock Date P/S P/B P/E EV/EBIT
MCK 2021-03-04 0.1 -57.5 -6.6 -6.9
MCK 2020-07-21 0.1 5.0 28.1 26.2
MCK 2017-02-03 0.1 3.8 15.4 12.0
MCK 2013-12-26 0.3 4.6 26.8 17.1
MCK 2011-10-31 0.2 2.8 17.3 10.5
MCK 2010-11-02 0.2 2.5 13.0 7.8

MCK Growth Metrics

  • Its 5 year revenue growth rate is now at 23.86%.
  • Its 3 year net cashflow from operations growth rate is now at 9.91%.
  • Its 5 year cash and equivalents growth rate is now at -25.08%.
MCK's revenue has moved up $39,695,000,000 over the prior 49 months.

The table below shows MCK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 238,228 4,542 -4,539
2020-12-31 237,621 5,826 -4,184
2020-09-30 234,194 4,492 2,228
2020-06-30 231,002 3,363 921
2020-03-31 231,051 4,374 900
2019-12-31 224,945 3,615 -917

MCK Price Target

For more insight on analysts targets of MCK, see our MCK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $224.23 Average Broker Recommendation 1.44 (Moderate Buy)

MCK Stock Price Chart Interactive Chart >

Price chart for MCK

MCK Price/Volume Stats

Current price $204.12 52-week high $205.36
Prev. close $202.50 52-week low $141.32
Day low $200.56 Volume 997,729
Day high $204.91 Avg. volume 1,119,425
50-day MA $193.39 Dividend yield 0.83%
200-day MA $182.74 Market Cap 32.29B

McKesson Corporation (MCK) Company Bio


Mckesson Corporation partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. The company was founded in 1833 and is based in San Francisco, California.

MCK Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$204.12$143.42 -29%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mckesson Corp. To summarize, we found that Mckesson Corp ranked in the 45th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Mckesson Corp, consider:

  • Mckesson Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -23.12. This coverage rate is greater than that of only 3.88% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 12. This value is greater than 87.68% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-31%
1%-30%
2%-29%
3%-29%
4%-28%
5%-27%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MCK, try SNY, ADUS, INFU, REGN, and ABT.


MCK Latest News Stream


Event/Time News Detail
Loading, please wait...

MCK Latest Social Stream


Loading social stream, please wait...

View Full MCK Social Stream

Latest MCK News From Around the Web

Below are the latest news stories about Mckesson Corp that investors may wish to consider to help them evaluate MCK as an investment opportunity.

McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share

IRVING, Texas, July 26, 2021--The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 23, 2021 a regular dividend of $0.47 per share of common stock, a 12% increase from $0.42 per share in the prior quarter. The dividend will be payable on October 1, 2021, to stockholders of record on September 1, 2021.

Yahoo | July 26, 2021

Big Data In Healthcare Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Philips, Tableau, SAS, Dell, Optum, Cisco, Mckesson, Cerner Corporation, Cognizant, Epic

This report studies the Big Data In Healthcare Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Big Data In Healthcare market segmented []

Jumbo News | July 24, 2021

Transparent Dressings Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:3M, HARTMANN, Coloplast, Nipro, Curad, JXTG Group, McKesson, Medtronic (Covidien), ConvaTe

This report studies the Transparent Dressings Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Transparent Dressings market segmented by company, region, type []

Jumbo News | July 24, 2021

Revenue Cycle Management (RCM) Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Athenahealth, Cerner Corporation, Eclinicalworks, Mckesson, Quest Diagnostics, Al

This report studies the Revenue Cycle Management (RCM) Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Revenue Cycle Management (RCM) market segmented []

Jumbo News | July 24, 2021

Healthcare Revenue Cycle Management (RCM) Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Epic Systems Corporation, McKesson Corporation, Cerner Corporation, Ge

This report studies the Healthcare Revenue Cycle Management (RCM) Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Healthcare Revenue Cycle Management (RCM) []

Jumbo News | July 24, 2021

Read More 'MCK' Stories Here

MCK Price Returns

1-mo 6.68%
3-mo 8.85%
6-mo 13.85%
1-year 31.16%
3-year 70.32%
5-year 10.87%
YTD 17.91%
2020 27.06%
2019 26.72%
2018 -28.40%
2017 11.95%
2016 -28.30%

MCK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MCK Dividend History

Continue Researching MCK

Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:

Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8949 seconds.